These results suggest that the downregulation of MITOL is one of the causes of cardiac damage in MI; the fact that ectopic expression of MITOL rescued the cardiac damage indicates that the OMMAD activation by MITOL can be a therapeutic target for MI. This evidence concerns the gene MARCHF5 and myocardial infarction.